BioSpace News Archive

Business

Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B

Bicycle Therapeutics and Novartis announced Tuesday they have inked a deal worth up to $1.7 billion to discover and develop targeted radioligand therapies in oncology.

March 28, 2023
·
2 min read
·
Rosemary Scott
Drug Development

Monopar Drops Lead Candidate after Disappointing Phase III Analysis

Monopar Therapeutics is dropping its lead candidate, Validive, after it failed to meet efficacy markers in Phase IIb/III trials for severe oral mucositis.

March 28, 2023
·
1 min read
·
Lisa Munger
Business

Evotec Up for Potential $4B More in Lucrative BMS Partnership

Bristol Myers Squibb is expanding its strategic collaboration with German partner Evotec for eight more years to discover and develop treatments for neurodegenerative diseases.

March 28, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Keytruda Maintains Edge over GSK’s Jemperli in Endometrial Cancer (Updated)

Merck’s Keytruda appeared to outperform GSK’s Jemperli in a key endometrial cancer patient subgroup, based on late-stage data revealed Monday during the Society of Gynecologic Oncology 2023 Annual Meeting.

March 28, 2023
·
2 min read
·
Tristan Manalac
Notch Therapeutics Promotes Chris Bond to Chief Scientific Officer

Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, is pleased to announce Dr. Chris Bond has been promoted to Chief Scientific Officer.

March 28, 2023
·
1 min read
Addex Therapeutics to Release Full-Year 2022 Financial Results and Host Conference Call on March 30, 2023

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that it will issue its full-year 2022 financial results on Thursday, March 30, 2023.

March 28, 2023
·
4 min read
Business

Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV

Vifor Fresenius Medical Care Renal Pharma is pleased to announce that Tavneos® has been included in the revised EULAR AAV management recommendations, as one of several important updates in the 2022 version.

March 28, 2023
·
5 min read
BioForest

Evotec SE Preliminary Fiscal Year 2022 Results: ‘Ahead of the Curve’ - Very Strong Performance in a Challenging Year

Evotec SE reported preliminary financial results and corporate updates for the fiscal year ended 31 December 2022.

March 28, 2023
·
12 min read
Biovica signs DiviTum(R) TKa Commercial Partner Agreement for Dutch and Polish Markets

Biovica, active in cancer monitoring, announces that the company has signed a commercial partnership with the European distributor TOROMEDICAL group for the commercialization of the DiviTumTKa test for clinical routine use in the Netherlands and Poland.

March 28, 2023
·
3 min read
Drug Development

EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy

EnteroBiotix Limited announced the initiation of a multi-centre randomised double-blind placebo controlled Phase 2 clinical trial.

March 28, 2023
·
4 min read